Elizabeth Livanos
- Oncology top 2%
- Cancer-related Molecular Pathways 5
- Biotechnology top 2%
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 4
- Molecular Biology top 5%
- Renal and related cancers 3
- Molecular Biology Techniques and Applications 2
- Pathology and Forensic Medicine top 10%
-
- Virus-based gene therapy research 3
-
- Cervical Cancer and HPV Research 2
-
- Microtubule and mitosis dynamics 2
-
- Effects and risks of endocrine disrupting chemicals 1
- Co-authors
- Thea D. TlstyLaura R. LivingstoneTyler JacksAlicia WhiteJean‐Michel H. VosSubrata BanerjeeD AraujoBernard E. Weissman
- Cited by
- OncologyBiotechnologyCancer Research
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
Elizabeth Livanos
17 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Oncology 1.2k
- Biotechnology 261
- Cancer Research 436
- Molecular Biology 1.3k
- Pathology and Forensic Medicine 205
Countries citing papers authored by Elizabeth Livanos
This map shows the geographic impact of Elizabeth Livanos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Livanos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Livanos more than expected).
Fields of papers citing papers by Elizabeth Livanos
This network shows the impact of papers produced by Elizabeth Livanos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Livanos. The network helps show where Elizabeth Livanos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elizabeth Livanos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 0 | |
| 2 | 2008 | 78 | |
| 3 | 2007 | 75 | |
| 4 | 2005 | 4 | |
| 5 | 2005 | 16 | |
| 6 | 1998 | 36 | |
| 7 | 1996 | 72 | |
| 8 | 1995 | 13 | |
| 9 | 1995 | 54 | |
| 10 | 1994 | 8 | |
| 11 | 1994 | 298 | |
| 12 | 1993 | 11 | |
| 13 | 1993 | 7 | |
| 14 | Multiple mechanisms of N-(phosphonoacetyl)-L-aspartate drug resistance in SV40-infected precrisis human fibroblasts. | 1993 | 38 |
| 15 | Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53breakdown → | 1992 | 1174 |
| 16 | 1992 | 85 | |
| 17 | 1991 | 27 | |
| 18 | 1991 | 101 |
About Elizabeth Livanos
Elizabeth Livanos is a scholar working on Cancer Research, Oncology and Endocrinology, having authored 18 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Cancer Genomics and Diagnostics (4 papers), Virus-based gene therapy research (3 papers), Renal and related cancers (3 papers), Cervical Cancer and HPV Research (2 papers), Molecular Biology Techniques and Applications (2 papers), Microtubule and mitosis dynamics (2 papers) and Effects and risks of endocrine disrupting chemicals (1 paper). The work is most often cited by research in Oncology (1.2k citations), Biotechnology (261 citations) and Cancer Research (436 citations). Elizabeth Livanos has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Thea D. Tlsty, Laura R. Livingstone, Tyler Jacks, Alicia White, Jean‐Michel H. Vos, Subrata Banerjee, D Araujo, Bernard E. Weissman, Eric J. Stanbridge and Clare L. Fasching. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.